• Brito-Babapulle, V., Garcia-Marco, J., Maljaie, S.H., Hiorns, L., Coignet, L., Conchon, M. & Catovsky, D. (1997) The impact of molecular cytogenetics on chronic lymphoid leukaemia. Acta Haematologica, 98, 175186.
  • Buhmann, R., Kurzeder, C., Rehklau, J., Westhaus, D., Bursch, S., Hiddemann, W., Haferlach, T., Hallek, M. & Schoch, C. (2002) CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells. British Journal of Haematolgy, 118, 968975.
  • Bullrich, F., Fujii, H., Calin, G., Mabuchi, H., Negrini, M., Pekarsky, Y., Rassenti, L., Alder, H., Reed, J.C., Keating, M.J., Kipps, T.J. & Croce, C.M. (2001) Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Research, 61, 66406648.
  • Cheson, B., Bennett, J., Grever, M., Kay, N., Keating, M., Obrien, S. & Rai, K. (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 49904997.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 18401847.
  • Dewald, G. (2002) Interphase FISH studies of chronic myeloid leukemia. In: Molecular Cytogenetics: Protocols and Applications, (ed. by Y.S.Fan) Vol. 204, pp. 311342. Humana Press, Totowa, NJ.
  • Dewald, G., Allen, J.E., Strutzenberg, D. & Pierre, R.V. (1982) A cytogenetic method for mailed-in bone marrow specimens for the study of hematologic disorders. Laboratory Medicine, 13, 225229.
  • Dohner, H., Stilgenbauer, S., James, M.R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W. & Lichter, P. (1997a) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 25162522.
  • Dohner, H., Stilgenbauer, S., Fischer, K., Bentz, M. & Lichter, P. (1997b) Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia, 11, s19s24.
  • Dohner, H., Stilgenbauer, S., Dohner, K., Bentz, M. & Lichter, P. (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. Journal of Molecular Medicine, 77, 266281.
  • Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 19101916.
  • El Rouby, S., Thomas, A., Costin, D., Rosenberg, C.R., Potmesil, M., Silber, R. & Newcomb, E.W. (1993) p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood, 82, 34523459.
  • Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S.L., Schulman, P., Vinciguerra, V.P., Rai, K., Rassenti, L.Z., Kipps, T.J., Dighiero, G., Schroeder, Jr, H.W., Ferrarini, M. & Chiorazzi, N. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation, 102, 15151525.
  • Finn, W.G., Kay, N.E., Kroft, S.H., Church, S. & Peterson, L.C. (1998) Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients. American Journal of Hematology, 59, 223229.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 18481854.
  • Hamblin, T.J., Orchard, J.A., Gardiner, A., Oscier, D.G., Davis, Z. & Stevenson, F.K. (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood, 95, 24552457.
  • Han, T., Ozer, H., Sadamori, N., Emrich, L., Gomez, G.A., Henderson, E.S., Bloom, M.L. & Sandberg, A.A. (1984) Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. New England Journal of Medicine, 310, 288292.
  • Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., Lerner, S., Kantarjian, H.M. & Albitar, M. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood, 98, 181186.
  • Jelinek, D., Tschumper, R., Geyer, S., Bone, N., Dewald, G., Hanson, C., Stenson, M., Witzig, T., Tefferi, A. & Kay, N. (2001) Analysis of clonal B cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukemia. British Journal of Haematology, 115, 854861.
  • Juliusson, G., Oscier, D.G., Fitchett, M., Ross, F.M., Stockdill, G., Mackie, M.J., Parker, A.C., Castoldi, G.L., Guneo, A., Knuutila, S., Elonen, E. & Gahrton, G. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New England Journal of Medicine, 323, 720724.
  • Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. & Stilgenbauer, S. (2002) VΗ mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 100, 14101416.
  • Larramendy, M.L., Siitonen, S.M., Zhu, Y., Hurme, M., Vilpo, L., Vilpo, J.A. & Knuutila, S. (1998) Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis: The Tampere Chronic Lympocytic Leukemia group. Cytogenetics and Cell Genetics, 82, 215221.
  • Neilson, J.R., Auer, R., White, D., Bienz, N., Waters, J.J., Whittaker, J.A., Milligan, D.W. & Fegan, C.D. (1997) Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia, 11, 19291932.
  • Rai, K., Dohner, H., Keating, M. & Montserrat, E. (2001) Chronic lymphyocytic leukemia: case-based session. In: Hematology 2001 (ed. byS.Gp), pp. 140156. American Society of Hematology, Orlando.
  • Zhang, Y., Weber-Matthiesen, K., Siebert, R., Matthiesen, P. & Schlegelberger, B. (1997) Frequent deletions of 6q23–24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Genes, Chromosomes and Cancer, 18, 310313.